Literature DB >> 31542871

A case of female Fabry disease revealed by renal biopsy.

Sae Aratani1, Hiroyuki Yamakawa2, Shinya Suzuki3, Tomoyuki Otsuka4, Yukinao Sakai5, Akira Shimizu6, Shuichi Tsuruoka5.   

Abstract

Fabry disease (FD) is an X-linked inherited glycosphingolipid metabolism disorder, therefore, heterozygous female FD patients display highly variable clinical symptoms, disease severity, and pathological findings. This makes it very challenging to diagnosing female patients with FD. A 69-year-old Japanese female was introduced to the nephrologist for the evaluation of proteinuria. A renal biopsy was performed. Although the light microscopic examinations revealed that most of the glomeruli showed minor glomerular abnormalities, however, vacuolation was apparently found in the tubular epithelial cells. Immunofluorescence staining for globotriaosylceramide was positively detected in some podocytes and distal tubular epithelial cells. In addition, myelin-like structure (zebra body) was detected by electron microscopy. Pathological findings were most consistent with FD. Consequently, biochemical and genetic analysis confirmed the diagnosis of female FD. Enzyme replacement therapy was performed in conjunction with renin-angiotensin aldosterone system inhibitors and beta-blockers. The patient's family members received the analysis, and the same DNA missense mutation was detected in the patient's grandson. The enzyme replacement therapy was introduced to the grandson. The present case showed that renal biopsy can contribute towards a correct diagnosis for FD. Particularly, in female FD patients, careful examination of pathological changes is essential, for example, vacuolation of any type of renal cells may be a clue for the diagnosis.

Entities:  

Keywords:  Enzyme replacement therapy; Fabry disease; Pathology; Renal biopsy; Vacuolation

Mesh:

Substances:

Year:  2019        PMID: 31542871      PMCID: PMC6990169          DOI: 10.1007/s13730-019-00420-5

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  18 in total

Review 1.  Renal pathology in Fabry disease.

Authors:  Joseph Alroy; Sharda Sabnis; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2002-06       Impact factor: 10.121

2.  Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease.

Authors:  Behzad Najafian; Einar Svarstad; Leif Bostad; Marie-Claire Gubler; Camilla Tøndel; Chester Whitley; Michael Mauer
Journal:  Kidney Int       Date:  2010-12-15       Impact factor: 10.612

3.  A heterozygous female with Fabry disease due to a novel α-galactosidase A mutation exhibits a unique synaptopodin distribution in vacuolated podocytes.

Authors:  Naoki Takahashi; Seiji Yokoi; Kenji Kasuno; Akiya Kogami; Takahiro Tsukimura; Tadayasu Togawa; Seiji Saito; Kazuki Ohno; Masanori Hara; Hiroyuki Kurosawa; Yoshiaki Hirayama; Tomomi Kurose; Yoshinari Yokoyama; Daisuke Mikami; Hideki Kimura; Hironobu Naiki; Hitoshi Sakuraba; Masayuki Iwano
Journal:  Clin Nephrol       Date:  2015-05       Impact factor: 0.975

4.  Clinical manifestations and natural history of Japanese heterozygous females with Fabry disease.

Authors:  M Kobayashi; T Ohashi; M Sakuma; H Ida; Y Eto
Journal:  J Inherit Metab Dis       Date:  2008-01-21       Impact factor: 4.982

5.  Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy.

Authors:  Raphael Schiffmann; David G Warnock; Maryam Banikazemi; Jan Bultas; Gabor E Linthorst; Seymour Packman; Sven Asger Sorensen; William R Wilcox; Robert J Desnick
Journal:  Nephrol Dial Transplant       Date:  2009-02-13       Impact factor: 5.992

6.  Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A).

Authors:  Wuh-Liang Hwu; Yin-Hsiu Chien; Ni-Chung Lee; Shu-Chuan Chiang; Robert Dobrovolny; Ai-Chu Huang; Hui-Ying Yeh; May-Chin Chao; Shio-Jean Lin; Teruo Kitagawa; Robert J Desnick; Li-Wen Hsu
Journal:  Hum Mutat       Date:  2009-10       Impact factor: 4.878

7.  Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.

Authors:  William R Wilcox; João Paulo Oliveira; Robert J Hopkin; Alberto Ortiz; Maryam Banikazemi; Ulla Feldt-Rasmussen; Katherine Sims; Stephen Waldek; Gregory M Pastores; Philip Lee; Christine M Eng; Laszlo Marodi; Kevin E Stanford; Frank Breunig; Christoph Wanner; David G Warnock; Roberta M Lemay; Dominique P Germain
Journal:  Mol Genet Metab       Date:  2007-11-26       Impact factor: 4.797

8.  Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.

Authors:  Alberto Ortiz; João P Oliveira; Steven Waldek; David G Warnock; Bruno Cianciaruso; Christoph Wanner
Journal:  Nephrol Dial Transplant       Date:  2008-01-05       Impact factor: 5.992

Review 9.  Screening for Fabry disease in high-risk populations: a systematic review.

Authors:  G E Linthorst; M G Bouwman; F A Wijburg; J M F G Aerts; B J H M Poorthuis; C E M Hollak
Journal:  J Med Genet       Date:  2009-09-24       Impact factor: 6.318

10.  Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy.

Authors:  Cristina Chimenti; Maurizio Pieroni; Emanuela Morgante; Daniela Antuzzi; Andrea Russo; Matteo Antonio Russo; Attilio Maseri; Andrea Frustaci
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.